{
  "Clinical Information": [],
  "Patent Information": [],
  "Sequence Information": {
    "ID": "AP04621",
    "Peptide Name": "LW-2 (Synthetic AMPs, Ala-rich,  XXA, UCLL1c)",
    "Source": "amino acid substitution, rationally designed",
    "Family": "Not found",
    "Gene": "Not found",
    "Sequence": "LWKAAAKAAAKLW",
    "Sequence Length": 13,
    "UniProt Entry": "Ref",
    "Protein Existence": "Not found",
    "Biological Activity": [
      "Anti-Gram+",
      "Gram-"
    ],
    "Target Organism": "Not found",
    "Hemolytic Activity": "Not found",
    "Cytotoxicity": "Not found",
    "Binding Target": "Not found",
    "Linear/Cyclic": "Not found",
    "N-terminal Modification": "Not found",
    "C-terminal Modification": "Not found",
    "Nonterminal Modifications and Unusual Amino Acids": "Not found",
    "Stereochemistry": "Not found",
    "Structure": "Helix",
    "Structure Description": "Not found",
    "Helical Wheel Diagram": "Not found",
    "PDB ID": "",
    "Predicted Structure": "Not found",
    "Formula": "Not found",
    "Absent Amino Acids": "Not found",
    "Common Amino Acids": "Not found",
    "Mass": "Not found",
    "PI": "Not found",
    "Basic Residues": "Not found",
    "Acidic Residues": "Not found",
    "Hydrophobic Residues": "Not found",
    "Net charge": 4,
    "Boman Index": -0.67,
    "Hydrophobicity": "Not found",
    "Aliphatic Index": "Not found",
    "Half Life": "Not found",
    "Extinction Coefficient Cystines": "Not found",
    "Absorbance 280nm": "Not found",
    "Polar Residues": "Not found",
    "Function": "Not found",
    "Hydrophobic residue%": "77%",
    "Crucial residues": ""
  },
  "Literature Information": {
    "Literature": "Sequence analysis: APD analysis reveals that this sequence is similar (84.62%) toKL4A6A: 46%, L=W: 15%, K: 23%.Activity: active against Gram- E. coli ATCC25922 or K88 or CVCC 1515 or UB1005 (MIC 4-8 uM), B. pyocyaneum ATCC 27853 (MIC 8 uM), S. typhimurium ATCC 14028 (MIC 32 uM), Gram+  S. aureus ATCC 29213 (MIC 8 uM) and S. epidermidis ATCC 12228 (MIC 8 uM).In vitro toxicity: 5% hemolysis concentration 256 uM.Structure: random coil in PBS and helical in 30 mM SDS or 50% TFE.",
    "Author": "Shao C, Li W, Lai Z, Akhtar MU, Dong N, Shan A, Ma D.2019",
    "Reference": "Chem Biol Drug Des. 2019 Dec;94(6):2051-2063. doi: 10.1111/cbdd.13608.PubMed",
    "Title": "Effect of terminal arrangement of tryptophan on biological activity of symmetric alpha-helix-forming peptides."
  },
  "3D Structure": []
}